PIK3CA and breast carcinoma: Furthermore, AKT seems to be a reasonable target for cancer therapy on the grounds that the PI3K/AKT signaling pathway is frequently dysregulated in up to 70% of human breast cancer [16] and upregulation of AKT in cancer is associated with overall poor prognosis [17].